Orbimed Capital LLC, Director at Repare Therapeutics Inc. (RPTX), sold 35,894 shares at $34.07 ($1.2M) on 2021-08-24, disclosed to the SEC on 2021-08-25.
Open-market sale of $1.2M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.06 | 209 | $7K | 0.6% |
| 2 | $34.06 | 6,885 | $235K | 19.1% |
| 3 | $34.06 | 6,885 | $235K | 19.1% |
| 4 | $34.07 | 119 | $4K | 0.3% |
| 5 | $34.07 | 3,920 | $134K | 10.9% |
| 6 | $34.07 | 3,920 |
| $134K |
| 10.9% |
| 7 | $34.34 | 208 | $7K | 0.6% |
| 8 | $34.34 | 6,874 | $236K | 19.2% |
| 9 | $34.34 | 6,874 | $236K | 19.2% |
| Total | $34.17 avg | 35,894 | $1.2M | 100% |
| Filing → |
| PRLD | BUY | 2023-05-24 | $10.0M | — | Filing → |
| ARQT | SELL | 2022-04-08 | $25.4M | — | Filing → |
| RPTX | SELL | 2021-08-30 | $993K | — | Filing → |